Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma -
WC Wood, DR Budman, AH Korzun, MR Cooper, J … - New England Journal of Medicine, 1994 - content.nejm.org
... Background Adjuvant chemotherapy is widely used for breast cancer and is
known to extend survival. Some clinicians seek a greater ...
Outcome of primary breast cancer patients with micrometastases: a long-term follow-up study -
JL Mansi, H Gogas, JM Bliss, JC Gazet, U Berger, … - feedback, 2005 - biomedcentral.com
... Although the widely used tumour-nodes-metastasis (TNM) staging system is generally
regarded as an effective prognostic index for breast cancer, the search ...
Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast Cancer -
A Goldhirsch, JH Glick, RD Gelber, AS Coates, HJ … - Journal of Clinical Oncology, 2001 - jco.ascopubs.org
... paclitaxel, as part of a standard adjuvant therapy for node-positive breast cancer. ...
Despite the fact that tamoxifen has been widely used for almost three ...
Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer -
JL Blum, SE Jones, AU Buzdar, PM LoRusso, I Kuter, … - Journal of Clinical Oncology, 1999 - jcojournal.org
... locoregional control, and adjuvant therapy, recurrent metastatic breast cancer remains
distressingly common. Systemic chemotherapy is widely used in this ...
… Thromboembolic Morbidity Among Postmenopausal Women With Early Stage Breast Cancer in a Randomized … -
LE Rutqvist - jnci, 1993 - jnci.oxfordjournals.org
... BACKGROUND: Tamoxifen, which binds to estrogen receptors, is widely used as
adjuvant therapy after surgery for early-stage breast cancer. ...
… in Postmenopausal Women After Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer. -
PE Goss, JN Ingle, S Martino, NJ Robert, HB Muss, … - Obstetrical & Gynecological Survey, 2004 - obgynsurvey.com
... Isosulfan blue dye was used to identify sentinel nodes. ... EDITORIAL COMMENT (In breast
cancer, malignant melanoma, and vulvar cancer, regional lymph node ...
UK and USA breast cancer deaths down 25% in year 2000 at ages 20?69 years -
R Peto, J Boreham, M Clarke, C Davies, V Beral - The Lancet, 2000 - Elsevier
... 1 and 2 (Radiotherapy, which reduces breast-cancer mortality, but which can increase
vascular mortality [see page 1757], has been used widely for decades ...
Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen -
KB Horwitz - Endocrinology, 1978 - Endocrine Soc
... Estrogen antagonists are widely used in the treatment of breast cancer, and studies
of their mechanism of action may provide clues to an understanding of tumor ...
… Chemotherapy for Invasive Breast Cancer: National Surgical Adjuvant Breast and Bowel Project … -
S Paik, J Bryant, E Tan-Chiu, G Yothers, C Park, … - jnci, 2000 - jnci.oxfordjournals.org
... to provide clinically relevant comparisons relating directly to treatment decisions
involving two widely used regimens for treating invasive breast cancer. ...
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer -
Y Wang, JGM Klijn, Y Zhang, AM Sieuwerts, MP Look, … - The Lancet, 2005 - Elsevier
... 60?70% of patients with lymph-node-negative breast cancer are cured by local or
regional treatment alone. 1 and 2 The most widely used treatment guidelines ...
Source: Google Scholar |